$17.71
0.95%
Nasdaq, Jul 03, 09:10 pm CET
ISIN
JE00BYSS4X48
Symbol
NVCR

Novocure Ltd. Target price 2025 - Analyst rating & recommendation

Novocure Ltd. Classifications & Recommendation:

Buy
77%
Hold
23%

Novocure Ltd. Price Target

Target Price $34.17
Price $17.71
Potential
Number of Estimates 9
9 Analysts have issued a price target Novocure Ltd. 2026 . The average Novocure Ltd. target price is $34.17. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 13 analysts: 10 Analysts recommend Novocure Ltd. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Novocure Ltd. stock has an average upside potential 2026 of . Most analysts recommend the Novocure Ltd. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 605.22 638.85
18.82% 5.56%
EBITDA Margin -25.98% -10.47%
40.36% 59.71%
Net Margin -27.86% -29.34%
31.46% 5.30%

9 Analysts have issued a sales forecast Novocure Ltd. 2025 . The average Novocure Ltd. sales estimate is

$639m
Unlock
. This is
2.76% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$667m 7.23%
Unlock
, the lowest is
$603m 3.05%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $605m 18.82%
2025
$639m 5.56%
Unlock
2026
$698m 9.19%
Unlock
2027
$797m 14.21%
Unlock
2028
$939m 17.83%
Unlock
2029
$1.4b 52.87%
Unlock
2030
$1.7b 21.25%
Unlock

6 Analysts have issued an Novocure Ltd. EBITDA forecast 2025. The average Novocure Ltd. EBITDA estimate is

$-66.9m
Unlock
. This is
56.24% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$3.6m 102.33%
Unlock
, the lowest is
$-180m 18.00%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-157m 29.13%
2025
$-66.9m 57.47%
Unlock
2026
$-53.7m 19.69%
Unlock
2027
$-7.5m 85.95%
Unlock
2028
$-51.7m 585.02%
Unlock

EBITDA Margin

2024 -25.98% 40.36%
2025
-10.47% 59.71%
Unlock
2026
-7.70% 26.46%
Unlock
2027
-0.95% 87.66%
Unlock
2028
-5.51% 480.00%
Unlock

9 Novocure Ltd. Analysts have issued a net profit forecast 2025. The average Novocure Ltd. net profit estimate is

$-187m
Unlock
. This is
14.17% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-180m 9.79%
Unlock
, the lowest is
$-194m 18.44%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-169m 18.55%
2025
$-187m 11.16%
Unlock
2026
$-204m 8.79%
Unlock
2027
$-165m 19.14%
Unlock
2028
$-102m 38.16%
Unlock
2029
$36.4m 135.69%
Unlock
2030
$293m 706.18%
Unlock

Net Margin

2024 -27.86% 31.46%
2025
-29.34% 5.30%
Unlock
2026
-29.23% 0.37%
Unlock
2027
-20.70% 29.18%
Unlock
2028
-10.86% 47.54%
Unlock
2029
2.54% 123.39%
Unlock
2030
16.86% 563.78%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.56 -1.68
20.00% 7.69%
P/E negative
EV/Sales 2.66

9 Analysts have issued a Novocure Ltd. forecast for earnings per share. The average Novocure Ltd. EPS is

$-1.68
Unlock
. This is
13.51% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-1.62 9.46%
Unlock
, the lowest is
$-1.74 17.57%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.56 20.00%
2025
$-1.68 7.69%
Unlock
2026
$-1.83 8.93%
Unlock
2027
$-1.48 19.13%
Unlock
2028
$-0.91 38.51%
Unlock
2029
$0.33 136.26%
Unlock
2030
$2.63 696.97%
Unlock

P/E ratio

Current -11.97 25.74%
2025
-10.53 12.00%
Unlock
2026
-9.68 8.07%
Unlock
2027
-11.97 23.66%
Unlock
2028
-19.36 61.74%
Unlock
2029
54.26 380.27%
Unlock
2030
6.73 87.60%
Unlock

Based on analysts' sales estimates for 2025, the Novocure Ltd. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.74 6.48%
2025
2.66 2.78%
Unlock
2026
2.44 8.42%
Unlock
2027
2.14 12.45%
Unlock
2028
1.81 15.13%
Unlock
2029
1.19 34.58%
Unlock
2030
0.98 17.53%
Unlock

P/S ratio

Current 3.18 9.43%
2025
3.09 2.68%
Unlock
2026
2.83 8.42%
Unlock
2027
2.48 12.45%
Unlock
2028
2.10 15.13%
Unlock
2029
1.38 34.58%
Unlock
2030
1.13 17.53%
Unlock

Current Novocure Ltd. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
Locked
Locked Jun 27 2025
Piper Sandler
Locked
Locked
Locked Apr 23 2025
Wedbush
Locked
Locked
Locked Apr 16 2025
JP Morgan
Locked
Locked
Locked Apr 10 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 14 2025
Piper Sandler
Locked
Locked
Locked Dec 13 2024
HC Wainwright & Co.
Locked
Locked
Locked Dec 03 2024
Analyst Rating Date
Locked
Piper Sandler:
Locked
Locked
Jun 27 2025
Locked
Piper Sandler:
Locked
Locked
Apr 23 2025
Locked
Wedbush:
Locked
Locked
Apr 16 2025
Locked
JP Morgan:
Locked
Locked
Apr 10 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 14 2025
Locked
Piper Sandler:
Locked
Locked
Dec 13 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Dec 03 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today